Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Brain Neoplasms 486Glioma 228Glioblastoma 224Neoplasms 62Neuroblastoma 56Central Nervous System Neoplasms 56Breast Neoplasms 54Meningioma 48Astrocytoma 43Neuroma, Acoustic 38Spinal Cord Neoplasms 35Neurofibromatosis 1 32Sarcoma 29Oligodendroglioma 29Lung Neoplasms 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma 27Neoplasm Metastasis 26Head and Neck Neoplasms 25Melanoma 22Lymphoma, Non-Hodgkin 22Leukemia 22Meningeal Carcinomatosis 21Medulloblastoma 21Hodgkin Disease 21Burkitt Lymphoma 20Testicular Neoplasms 19Lymphoma, Follicular 19Multiple Myeloma 18Gliosarcoma 18

Interventions

Genetic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Dyslexia × CNS × Clear all
NCT00624234 2025-07-08

Neurobiology and Treatment of Reading Disability in NF-1

Vanderbilt University

Phase NA Completed
184 enrolled 10 charts
CNS

Dyslexia, Learning Disabilities, Neurofibromatosis 1

NCT02422732 2015-08-19

Functional Imaging and Reading Deficit in Children With NF1

University Hospital, Toulouse

Phase NA Completed
25 enrolled
CNS

Dyslexia, Neurofibromatosis 1

NCT02397967 2015-03-26

Reading Disability in Children With NF1

University Hospital, Toulouse

Phase NA Completed
181 enrolled
CNS

Dyslexia, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡